Background: NLG207 (formerly CRLX101) is an investigational nanoparticle-drug conjugate (NDC) composed of a cyclodextrin-based polymer backbone linked to camptothecin, a topoisomerase-1 inhibitor. NDCs enhance drug delivery to tumors where gradua...查看全文
财报提醒2018-10-19 08:05
$NewLink Genetics Corporation (NLNK)$ NewLink Genetics to Host Its Third Quarter 2018 Financial Results Conference Call on November 1, 2018 网页链接查看全文
WitnessBio2018-08-01 09:00
$NewLink Genetics Corporation (NLNK)$ Hammered by a series of setbacks, NewLink axes staff (again) and circles its wagons around troubled IDO program.
Endpoints查看全文
$Newlink(NLNK)$ 内部交易: 2015-10-07,董事会主席 and CEO,Link Charles J. Jr. ,卖出,10000普通股, $35.16
$Newlink(NLNK)$ 内部交易: 2015-10-05,董事会主席 and CEO,Link Charles J. Jr. ,卖出,15000普通股, $37.36
$Newlink(NLNK)$ 内部交易: 2015-09-11,总裁, Chief Medical Offic,Vahanian Nicholas N. ,卖出,10000普通股, $51.19
$Newlink(NLNK)$ 内部交易: 2015-09-11,总裁, Chief Medical Offic,Vahanian Nicholas N. ,期权,10000普通股, $2.10
$Newlink(NLNK)$ 内部交易: 2015-09-04,董事会主席 and CEO,Link Charles J. Jr. ,卖出,12500普通股, $44.87
$Newlink(NLNK)$ 内部交易: 2015-09-03,董事会主席 and CEO,Link Charles J. Jr. ,卖出,7500普通股, $45.14
$Newlink(NLNK)$ 美东时间 2015-09-10 09:05 NewLink Genetics Corp at Robert W Baird and Co Health Care Conference 网页链接
$Newlink(NLNK)$ 内部交易: 2015-08-03,总裁, Chief Medical Offic,Vahanian Nicholas N. ,卖出,10000普通股, $51.77
$Newlink(NLNK)$ 内部交易: 2015-08-03,总裁, Chief Medical Offic,Vahanian Nicholas N. ,期权,10000普通股, $2.10
$Newlink(NLNK)$ 美东时间 2015-07-31 09:00 Before Open:NEWLINK GENETIC Earning Release . Wall St EPS Est ($):-0.64. 网页链接